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Abstract
Purpose To compare the safety of on- vs off-clamp robotic partial nephrectomy (RAPN).
Methods 302 patients with RENAL masses ≤ 10 were randomized to undergo on-clamp (150) vs off-clamp (152) RAPN 
(CLOCK trial—ClinicalTrials.gov NCT02287987) at seven institutions by one experienced surgeon per institution. Intra-
operative data, complications, and positive surgical margins were compared.
Results Due to a relevant rate of shift from the assigned treatment, the per-protocol analysis only was considered and the 
data from 129 on-clamp vs 91 off-clamp RAPNs analyzed. Tumor size (off-clamp vs on-clamp, 2.2 vs 3.0 cm, p < 0.001) 
and RENAL score (5 vs 6, p < 0.001) significantly differed. At univariate analysis, no differences were found regarding 
intra-operative estimated blood loss (off- vs on-clamp, 100 vs 100 ml, p = 0.7), post-operative complications rate (19% vs 
26%, p = 0.2), post-operative anemia (Hb decrease > 2.5 g/dl 26% vs 27%, p = 0.9; transfusion rate 3.4% vs 6.3%, p = 0.5; 
re-intervention due to bleeding 1.1% vs 4%, p = 0.4), acute kidney injury (4% vs 6%, p = 0.8), and positive surgical margins 
(3.5% vs 8.2%, p = 0.1). At multivariate analysis accounting for tumor diameter and complexity, considering the on-clamp 
group as the reference category, a significant difference was noted in the off-clamp group exclusively for blood loss (OR 
0.3, 95% CI 0.09–0.52, p = 0.008).
Conclusions The on-clamp and off-clamp approaches for RAPN showed a comparable safety profile.
Keywords Partial nephrectomy · Robot · Clamping · On-clamp · Off-clamp · Clampless
Introduction
The current guidelines recommend partial nephrectomy 
(PN) as treatment option for T1 renal masses suspicious for 
cancer [1, 2]. Beyond the oncological aim, the goal of PN is 
to maximize the preservation of renal function [2, 3].
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Several factors have been described to interplay in the 
functional outcomes after PN. These are represented by 
unmodifiable patient’s factors (age, comorbidities, and base-
line kidney function), and modifiable surgical factors (the 
renal pedicle management, the resection, and renorrhaphy 
technique) either determining the final amount of the pre-
served vascularized parenchyma and thus the ultimate renal 
function [4, 5].
During the last 2 decades, the ischemia time has been 
emphasized among the main factors of kidney function 
impairment after PN [6]. Nevertheless, several studies 
showed that ischemia time longer than 30 min could be 
acceptable in the setting of bilateral kidneys [7]. The aim 
to reduce ischemia time led some authors to push PN to the 
limit of no ischemia [8]. Actually, during open surgery an 
“off-clamp” technique is more likely to be performed given 
the direct hand-assisted control by the surgeon [9]. Con-
versely, this approach is more demanding during minimally 
invasive PN. First described by Guillonneau et al. [10], some 
authors duplicated the off-clamp approach during laparo-
scopic PN, showing that this is a challenging approach, 
requiring consistent experience. It was later reproduced 
with the advent of robotic surgery [11]. Robot-assisted PN 
(RAPN) has gained popularity in the last decade thanks to 
the undoubted advantages intrinsic with the robotic platform 
[12, 13]. As such, it has widened the indications to nephron-
sparing surgery. On the other hand, it has been hypothe-
sized that choosing an off-clamp approach might negatively 
impact on the perioperative outcomes. Indeed, higher blood 
loss could be responsible of vision worsening increasing the 
risk of surgical complications and positive surgical margins.
Our research group sought to raise the bar, aiming to 
increase the level of evidence about the topic in the setting 
of a randomized clinical trial (RCT), the “CLOCK” study 
(CLamp vs Off Clamp the Kidney during robotic partial 
nephrectomy; ClinicalTrials.gov NCT 02287987). The pre-
sent analysis concerns with some secondary endpoints of 
the CLOCK trial, with the aim to compare the surgical and 
oncological safety of on-clamp vs off-clamp RAPN.
Materials and methods
Trial design, participants
The CLOCK Robotic study is a multi-centric RCT promoted 
by the AGILE group (Italian group for advanced laparo-
endoscopic surgery, http://www.agile group .it) started in 
September 2014 and closed in November 2018. The study 
received ethics committee approval (registration number NP 
1814).
The study protocol was described elsewhere [14]. Briefly, 
all the consecutive candidates fulfilling the inclusion criteria 
(preoperative glomerular filtration rate (eGFR) > 60 ml/min 
as estimated by the CKD-EPI equation [15]; normal con-
tralateral kidney; renal mass complexity ≤ 10 as assessed by 
RENAL score [16]) were randomized to undergo on-clamp 
or off-clamp RAPN at 7 Institutions. At each center, only 
one single experienced robotic surgeon with a detailed sur-
gical profile (35/40 years, prior experience in laparoscopic 
renal surgery and at least 100 RAPNs with various clamping 
approaches prior to the study start) was involved to ideally 
homogenize the surgical expertise. At baseline, a renal scan 
was prescribed to assess split renal function.
Sample size
The primary endpoint of the study was the baseline/post-
operative eGFR variation at 3/6  months. The minimal 
required sample size was 102 + 102 patients, calculated on 
an expected difference of 20 ml/min between arms accord-
ing to the best evidence available at the time of study design 
[17]. Considered the occurrence of shifts from the assigned 
arm, the enrollment period was prolonged as far as at least 
200 patients underwent the desired treatment, to achieve the 
planned minimal sample size.
Randomization
The random sequence was computer generated with a 1:1 
ratio allocation assigned by a permuted block design, strati-
fied by center [18] and according to the complexity of the 
tumor based on the RENAL score. The allocation arm was 
notified to surgeons just before starting the procedure by a 
dedicated internet-based e-form, managed by an independent 
software house.
Interventions
The surgical strategy was strictly regulated by the study 
protocol: kidney defatting, renal artery isolation, and sus-
pension were mandatory steps. In the on-clamp treatment 
group, tumor resection and inner renorrhaphy layer had to be 
done under ischemia, whereas in the off-clamp arm, the renal 
artery had to remain unclamped throughout the whole pro-
cedure. All the participating surgeons were able to perform 
both trans- and retroperitoneal accesses, adopted according 
to tumor’s position or patient’s previous surgical history. At 
any moment, the investigators were able to change to the 
alternative randomization arm, detailing the timing and the 
reasons of the decision.
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Outcomes
Patients’ demographics, baseline characteristics, perio-
perative, and post-operative data were collected on elec-
tronic forms, accessible only to the project statistician. 
Patients’ comorbidities were classified according to the 
Charlson–Romano index [19]. The resection technique was 
classified by the recently published and validated Surface-
Intermediate Base (SIB) score [20, 21]. The severity of 
intra-operative bleeding was categorized on a scale from 
0 (no bleeding) to 5 (intense bleeding exceeding the suc-
tion capacity). Post-operative complications were classified 
according to the Clavien–Dindo system [22]. Pathologi-
cal specimen examination was done at each Institution by 
experienced dedicated uro-pathologists, blinded to clamping 
approach, according to international guidelines; no central 
revision of slides was done. A further renal scan was pre-
scribed at baseline and after 3/6 months.
For the purpose of the present study—i.e., to assess the 
safety of on- vs off-clamp RAPN—the following endpoints 
were compared:
(a) Intra-operative estimated blood loss (EBL, continuous 
variable);
(b) Post-operative complications rate;
(c) Post-operative anemia, described by:
(a) A decrease in hemoglobin levels ≥ 2.5 g/dl;
(b) Transfusion rate;
(c) Re-intervention (surgical or angiographic) due to 
bleeding.
(d) Post-operative acute kidney injury (AKI) rate 
(increase > 50% in serum creatinine [23]);
(e) Positive surgical margins (PSM).
Statistical methods
Categorical variables were summarized as absolute and rela-
tive frequencies, while numerical variables as median and 
interquartile range (IQR).
The Kruskal–Wallis rank test and the Fisher’s exact test 
were used to compare medians and proportions between 
treatment groups, respectively. Multivariable logistic 
regression models were estimated to compare outcomes’ 
distributions in off- and on-clamp approaches accounting 
for potential confounders. All tests were two-sided and a 
p value < 0.05 was considered statistically significant. All 
calculations were performed using Stata 15.0 (StataCorp. 
2017. Stata Statistical Software: Release 15. College Station, 
TX: StataCorp LLC).
Results
Up to October 2018, 343 patients were assessed to be 
enrolled in the CLOCK study; 41 patients were excluded 
after accounting for inclusion criteria. Actually, 302 patients 
were recruited: 150 were randomly assigned into the on-
clamp and 152 in the off-clamp treatment group. The num-
ber of recruited patients exceeded the planned sample size 
because of relevant rate (61/152 patients, 40%) of change to 
the off-clamp arm, in relationship with tumor’s diameter and 
complexity [24]. At a lesser extent (21/150 patients, 14%), 
some cases randomly assigned to the on-clamp group were 
shifted to the off-clamp one as well, following the surgeon’s 
preference.
Intention‑to‑treat analysis
The on-clamp (150 patients) and off-clamp (152 patients) 
were well balanced regarding demographic and anthropo-
metric data, serum examinations, comorbidities, and clinical 
size. In particular, eGFR and split renal function and renal 
scintigraphy were equivalent. An imbalance was noted for 
median RENAL score (median value off- vs on-clamp 6 vs 
7, p < 0.001, Table 1). Given the rate of cases shifted from 
the assigned treatment, the intention-to-treat analysis was 
hindered as poorly representative of the effective treatment 
received by patients.
Per‑protocol analysis
The per-protocol analysis included only the patients who 
actually completed the treatment they were allocated to, 
represented by 129 on-clamp vs 91 off-clamp RAPNs. A 
statistically significant difference, with marginal clinical 
relevance, was noted in clinical tumor size (off-clamp vs 
on-clamp group, median diameter 2.2 vs 3.0 cm, p < 0.001), 
RENAL score (median 6 vs 7, p < 0.001), and prevalence of 
cardiac disease (10% vs 24%, p = 0.02) (Table 1).
Several differences emerged in intra-operative data: the 
off clamp procedures were preferentially done by retrop-
eritoneal approach (22% vs 8%, p = 0.005), within a shorter 
operative time (115 min vs 120 min, p = 0.005) and less 
frequently with a single-layer renorrhaphy (65% vs 84%, 
p = 0.01). In addition, the subjective perception of severe 
bleeding was more frequent in off-clamp group (score ≥ 3 
22% vs 9%, p = 0.01) (Supplementary Table 1).
Concerning the endpoints of the study, no statistically sig-
nificant difference was found between groups at univariable 
analysis. Indeed, intra-operative EBL (off- vs on-clamp, 100 
vs 100 ml, p = 0.7), post-operative complications rate (Over-
all 19% vs 26%, p = 0.2; Clavien ≥ 2 8% vs 12%, p = 0.4), 
post-operative anemia (Hb decrease > 2.5 g/dl 26% vs 27%, 
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Table 1  Baseline features according to intention-to-treat and per-protocol analysis
Intention-to-treat analysis On-clamp (n = 150) Off-clamp (n = 152) p value
Gender 0.8
 Female 62 (41.3) 60 (39.5)
 Male 88 (58.7) 92 (60.5)
Age, years 63.0 (54.0–70.0) 66.0 (55.0–71.0) 0.2
BMI, kg/m2 26.3 (24.7–28.6) 26.1 (24.2–28.4) 0.3
Platelets count 220.500 (181,250–268,750) 215,500 (185,000–259,250) 0.7
Hemoglobin, g/dl 14.0 (12.9–14.9) 14.3 (13.3–15.2) 0.2
Hematocrit,  % 42.4 (40.0–44.7) 42.9 (40.2–45.7) 0.3
PT, % 98.0 (94.0–100.0) 99.0 (94.0–100.0) 0.6
PTT, s 29.9 (27.9–32.2) 29.9 (27.1–32.7) 0.9
GFR, ml/min 93.1 (80.0–110.0) 92.0 (78.4–108.4) 0.7
Operated kidney % SRF 48.3 (46.0–51.0) 49.0 (47.0–52.0) 0.3
Hypertension 78 (52) 88 (57.9) 0.4
Diabetes 19 (12.7) 17 (11.2) 0.7
Vascular disease 26 (17.3) 22 (14.5) 0.5
Cardiac disease 37 (24.8) 24 (15.9) 0.06
Urinary obstruction 2 (1.4) 0 (0) 0.2
ECOG performance status 0.1
 0 109 (73.2) 126 (82.9)
 1 32 (21.5) 23 (15.1)
 > 2 8 (5.4) 3 (2)
Charlson’s comorbidity index 0.6
 0 88 (60.3) 93 (62.8)
 1 35 (24) 38 (25.7)
 2 11 (7.5) 8 (5.4)
 > 2 12 (8.3) 9 (6.1)
Clinical tumor size, cm 3.0 (2.2–4.0) 2.6 (2.0–3.7) 0.07
RENAL score 7.0 (5.2–8.0) 6.0 (5.0–7.0) < 0.001
Per-protocol analysis On-clamp (n = 129) Off-clamp (n = 91) p value
Gender 0.8
 Female 52 (40.3) 39 (42.9)
 Male 77 (59.7) 52 (57.1)
Age, years 62.0 (53.0–70.0) 66.0 (54.5–70.0) 0.4
BMI, kg/m2 26.0 (24.5–28.4) 26.2 (23.9–28.8) 0.9
Platelets count 221,000 (182,000–268,000) 214,000 (186,500–254,000) 0.4
Hemoglobin, g/dl 14.0 (13.0–14.9) 14.3 (13.2–15.1) 0.3
Hematocrit, % 42.0 (40.0–44.5) 42.5 (40.1–44.9) 0.5
PT, % 97.0 (93.0–100.0) 99.0 (95.0–100.0) 0.2
PTT, s 30.0 (27.9–32.2) 29.5 (27.1–32.0) 0.4
eGFR, ml/min 86.2 (73.1–96.0) 87.9 (78.1–100.3) 0.2
GFR, ml/min 93.1 (80.0–110.0) 97.0 (83.9–111.1) 0.3
Operated kidney % SRF 48.1 (45.9–51.0) 49.0 (47.0–51.4) 0.1
Hypertension 65 (50.4) 48 (52.7) 0.8
Diabetes 14 (10.9) 11 (12.1) 0.8
Vascular disease 21 (16.3) 10 (11) 0.3
Cardiac disease 31 (24.2) 10 (11.1) 0.02
Urinary obstruction 2 (1.7) 0 (0) 0.5
ECOG performance status 0.09
 0 96 (75) 80 (87.9)
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p = 0.9; transfusion rate 3.4% vs 6.3%, p = 0.5; re-interven-
tion due to bleeding 1.1% vs 4%, p = 0.4), AKI (4% vs 6%, 
p = 0.8), and PSM (3.5% vs 8.2%, p = 0.1) were similar (Sup-
plementary Table 1).
To account for the baseline unbalances in tumor diam-
eter and complexity, multivariable model analysis was 
performed too (Supplementary Table 2). Considering the 
on-clamp group as the reference category, a statistically 
significant difference was noted in the off-clamp group 
exclusively for EBL [odds ratio (OR)] 0.3, 95% confidence 
interval (CI) 0.08–0.52, p = 0.008), while no significant dif-
ferences emerged for the others endpoints (post-operative 
complications: OR 0.68, 95% CI 0.32–1.44, p = 0.3; Hb 
decrease > 2.5 g/dl: OR 1.29, 95% CI 0.64–2.63, p = 0.5; 
need for transfusions: OR 0.41, 95% CI 0.10–1.7, p = 0.2; 
AKI: OR 1.01, 95% CI 0.27–3.76, p = 1; PSM: OR 0.62, 
95% CI 0.14–2.85, p = 0.5).
Discussion
The CLOCK trial represents the largest randomized study 
attempting to assess whether an off-clamp vs an on-clamp 
approach to RAPN provides different outcomes. Notwith-
standing the involvement of surgeons out of the RAPN learn-
ing curve and their direct involvement into the study design, 
the indication from randomization was disregarded in a rel-
evant rate of cases. This mostly when the characteristic of 
tumors indicated on-clamp approach more suitable than the 
off-clamp one [24]. At a lesser extent, the surgeons shifted 
to off-clamp when the on-clamp approach was ethically con-
sidered as “overtreatment”. This rate of shift appeared as 
impressive and attributable to the inclusion of masses with a 
wide degree of complexity and the clinical setting of a RCT. 
Unfortunately no comparisons with other experiences can be 
done, because this data so far was unreported.
These events favored a statistically significant unbalance 
in tumor’s size and complexity that needed to be controlled 
by multivariable models. The herein reported comparison 
did not find any statistically significant difference in sur-
gical and oncological safety between the off- vs on-clamp 
RAPN. Post-operative complications, anemia, AKI, and 
PSM were overlapping at rough comparisons and at multi-
variable analysis, although a favorable clinical trend, statisti-
cally insignificant, was noted for the off-clamp group. Only 
a statistically significantly reduced EBL was found, without 
clinical implications.
To the best of our knowledge, this is the largest cohort 
prospective randomized trial seeking for more definitive 
conclusion about the impact on perioperative outcomes 
of renal pedicle management during RAPN. These results 
could straight be generalized considering that the CLOCK 
trial was conducted within a “real life scenario” involving 
multiple surgeons and institutions and this should have miti-
gated the effects of single-surgeon-specific features. As pre-
viously reported [25], surgeon experience is a major driver 
of PN outcomes and the results of this study could be dif-
ferent in another “context”. To address this issue, a detailed 
surgeon’s profile was demanded, so that operators had a 
homogenous background. Furthermore, surgical context 
was well standardized, being patient’s selection and surgi-
cal steps regulated by the study design. Definitely, the study 
was conducted under strict conditions concerning surgeons, 
patients (no CKD) and renal masses (RENAL up to 10), 
mainly with the intention to preserve patient’s safety and 
favor the acceptance of a RCT regulating a surgical proce-
dure. The results can be generalized to a considerable num-
ber of contemporary “robotic” institutions, generally pro-
vided by surgeons with similar features. At the same time, 
the study population is well representative of the majority 
of candidates to on- and off-clamp RAPN, since in presence 
of CKD or larger and more complex masses, most of sur-
geons will not opt for on- or off-clamp RAPN, respectively. 
Table 1  (continued)
Per-protocol analysis On-clamp (n = 129) Off-clamp (n = 91) p value
 1 25 (19.5) 9 (9.9)
 > 2 7 (5.5) 2 (2.2)
Charlson’s comorbidity index 0.7
 0 78 (62.4) 54 (62.1)
 1 27 (21.6) 22 (25.3)
 2 10 (8) 6 (6.9)
 > 2 10 (8) 5 (5.7)
Clinical tumor size, cm 3.0 (2.2–4.0) 2.2 (2.0–3.0) < 0.001
RENAL score 7.0 (6.0–9.0) 6.0 (4.0–7.0) < 0.001
PT prothrombin time, PTT partial thromboplastin time, SRF split renal function, GFR glomerular filtration rate, ECOG eastern cooperative 
oncology group
Author's personal copy
 World Journal of Urology
1 3
Reasonably, less experienced surgeons should expect a 
higher rate of transition from an attempted off- to on-clamp 
RAPN, and therefore during their learning curve they should 
limit this approach to the less complex masses. Originally, 
a standardized system—SIB score [20, 21]—described the 
dissection strategy, finding that off-clamp RAPNs were more 
frequently approached by enucleation, reasonably due to the 
intention to limit bleeding by dissecting on the plan of the 
tumor pseudocapsule.
Up-to-date, systematic reviews of the literature showed no 
impact of the technique used to manage the renal pedicle on 
either surgical or oncological outcomes of RAPN [26, 27]. 
However, the finding is debated because based on pooled 
analyses of mostly small sample size studies, affected by 
several confounders, selection bias, and heterogeneity in the 
surgical techniques used.
A recent propensity-score comparison matched the cases 
from two high-volume centers with exclusive off- or on-
clamp approach [28]: 400 on-clamp vs 200 off-clamp RAPN 
patients were analyzed after balancing several patient’s and 
tumor’s features (including solitary kidney status, baseline 
eGFR, tumor size and RENAL score). The authors found no 
significant differences in key perioperative outcomes, con-
firming the literature trend once again.
Anderson et al. recently published a single-center single-
surgeon prospective RCT addressing the comparison of on-
clamp vs off-clamp RAPN [29]. Thirty-seven vs 34 patients 
were analyzed, but the observed difference in the  % change 
of GFR between the treatment groups did not mirrored what 
was hypothesized at the power analysis time. A reasonable 
explanation might reside in the small sample size. The main 
point of the Anderson’s RCT was finding comparable out-
comes, as well as the only one shift from off-clamp to clamp 
detection probably sponsored by the single-surgeon setting 
of the study [30].
Noteworthy, our study showed no difference in the early 
functional outcomes, described as the change in eGFR and 
development of AKI. Conversely, the previous literature 
reported off-clamp approach to provide an advantage on 
immediate post-operative renal function [26–28]. Given 
the well-recognized negative prognostic role of AKI on 
late renal function [31], our finding offers another element 
in favor of a clamped approach with restricted ischemia 
time. Probably, other markers such as serum cystatin C and 
urinary neutrophil gelatinase-associated lipocalin would 
allow for an earlier detection of such damage to highlight 
a difference between to clamp or not [32]. The final analy-
sis of the CLOCK trial, focused on the primary endpoint, 
i.e., the global and split renal function at 3/6 months, will 
provide further elements to this discussion.
Our data confirm that during off-clamp approach, there 
is a subjective perception of major bleeding, despite the 
EBL was definitely lower at multivariable analysis. There 
is consensus among the detractors of this approach that 
bleeding worsens the quality of resection and exposes to 
the risk of PSM. On the other side, the supporters claim 
that the direct vision of bleeders allows a more effective 
renorrhaphy. The results of the present trial mitigate the 
controversy showing equal safety between approaches and 
support the safety of the clampless one whenever manda-
torily required, as in single kidney, baseline CKD or renal 
artery disease.
Despite the randomized controlled design, the present 
study is not devoid of limitations. The major one is that the 
study was not powered on the set of endpoints here inves-
tigated and, together with the lack of long-term controls, 
suggests caution before taking definitive conclusions, 
despite the consistency of results showing the equivalence 
between groups. Nevertheless, the results homogeneously 
show the equivalence between groups, improving the reli-
ability of findings. Another major limitation is given by 
the unbalances of baseline tumor’s dimensions and com-
plexity that emerged as statistically significant, although 
with marginal clinical relevance (median difference of 
0.8 cm in tumor size and 1 point in RENAL score). As a 
consequence, the “strengths” of randomization concerning 
the intention-to-treat analysis were lost, so that it was hin-
dered as poorly representative of the received treatment. 
Such a consideration enters within the ongoing debate 
on underreported limits of RCTs, especially in surgery 
[33]. Other imbalances concerned trans- vs retroperito-
neal approach and renorrhaphy technique, but were not 
included into models given that preliminary exploratory 
analyses—not shown—excluded a significant relationship 
with outcomes. However, the influence of these factors 
on intra- and post-operative events cannot be completely 
excluded, also considering the previous reports [4, 7, 34], 
and did not emerge reasonably due to the small size of 
the cohort. In addition, only expert surgeons and referral 
institutions joined the project and patients had baseline 
eGFR > 60 ml/min, a contralateral normal kidney and a 
renal mass RENAL ≤ 10, following the inclusion criteria. 
Another bias given by unmeasurable surgeon’s skills, as 
well his/her attitude and experience towards a specific 
clamping approach should be considered. Finally, it could 
be hypothesized that the peculiar setting of a surgical RCT 
could have prompted some additional care to preserve 
patient’s safety influencing the results with respect to the 
daily clinical practice.
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Conclusions
The present study shows that the off-clamp approach to 
RAPN offers at least equal safety than on-clamp in terms 
of intra-, post-operative complications and occurrence of 
PSM.
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